Aligos Therapeutics's total assets for Q3 2025 were $109.76M, a decrease of -18.52% from the previous quarter. ALGS total liabilities were $37.93M for the fiscal quarter, a 15.50% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.